DCF Advisers, LLC - AERIE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
DCF Advisers, LLC ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$2,385,000
+90.2%
157,665
-5.7%
1.54%
+106.3%
Q2 2022$1,254,000
-27.3%
167,165
-11.8%
0.75%
-1.2%
Q1 2022$1,725,000
+28.0%
189,565
-1.3%
0.76%
+38.2%
Q4 2021$1,348,000
-13.4%
192,065
+40.7%
0.55%
-20.4%
Q3 2021$1,556,000
+6.4%
136,501
+49.5%
0.69%
+32.6%
Q2 2021$1,462,000
-11.6%
91,300
-1.3%
0.52%
-28.0%
Q1 2021$1,653,000
+249.5%
92,500
+164.3%
0.72%
+268.7%
Q4 2020$473,000
-4.4%
35,000
+70.7%
0.20%
-37.7%
Q4 2019$495,00020,5000.31%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 246,563$2,244,0001.36%
LEVIN CAPITAL STRATEGIES, L.P. 1,435,876$13,066,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,695,020$42,725,0000.96%
DCF Advisers, LLC 189,565$1,725,0000.76%
DAFNA Capital Management LLC 289,040$2,630,0000.68%
RICE HALL JAMES & ASSOCIATES, LLC 1,678,609$15,275,0000.61%
Rhenman & Partners Asset Management AB 589,200$5,362,0000.53%
PFM Health Sciences, LP 1,088,566$9,906,0000.37%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$2,819,0000.36%
Granahan Investment Management 1,588,944$14,459,0000.36%
View complete list of AERIE PHARMACEUTICALS INC shareholders